EnterpriseDB (EDB), a leading sovereign AI and data company, is launching the Postgres Vitality Index, a framework measuring the breadth and depth of commercial contributions shaping the future of ...
The AI economy is projected to reach $17 trillion by 2028, fundamentally altering how organizations architect their infrastructure. Driven by this shift, 95% of major global enterprises are on a ...
As companies race to adopt agentic AI to spur innovation and gain efficiency, building the right enterprise data infrastructure has become a critical component of success. In partnership withSAP In ...
Microsoft Excel remains a cornerstone for data analysts, offering a wide array of functions to streamline workflows and enhance data accuracy. In this deep dive, Mo Chen highlights ten essential Excel ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Soroosh Khodami discusses why we aren't ready ...
Months after announcing a new program to validate self-reported nursing home quality data, the Centers for Medicare & Medicaid Services has begun notifying providers of their selection. Multiple ...
EnterpriseDB (EDB), a leading sovereign AI and data company, announced new investments in petabyte-scale analytics, expanding EDB Postgres AI (EDB PG AI) for WarehousePG with real-time streaming and ...
The workshop focuses on data categorisation and sharing, cross-border data flows, and open data. The frameworks aim to protect sensitive data while enabling secure cross-border sharing, supporting ...
Multimodal Artificial Intelligence Model From Baseline Histopathology Adds Prognostic Information for Distant Recurrence Assessment in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor ...
Tiger Data is the modern cloud platform built on PostgreSQL for time-series, events and analytics. Tiger Data is the modern cloud platform built on PostgreSQL for time-series, events and analytics.
Europe’s leading cancer conference may be swimming in antibody-drug conjugate data, but AstraZeneca remains convinced that its in-house pipeline sets the pharma apart. The U.K.-based drugmaker earned ...